Matt is responsible for all aspects of strategy, marketing, and business development at Veeva Systems. In 2007, Matt was named to the PharmaVOICE 100, which recognizes the 100 most influential people in the life sciences industry. Matt comes to Veeva from Health Market Science (HMS), a leading healthcare data services company, where he was Chief Marketing Officer. Prior to HMS, Matt was Vice President of Marketing & Product Management at IntelliChem, an enterprise software company acquired by Symyx Technologies in 2004. Prior to his small company forays, Matt was the General Manager of the Pharmaceuticals & Biotechnology division at Siebel Systems, which has since been acquired by Oracle. During his time at Siebel, Matt was responsible for building this global division, which grew from its inception to over $140 million under his leadership, capturing greater than 80% market share in the pharma CRM and clinical trial management (CTM) markets. At one point, nearly half of all pharma sales reps on earth used the products created during his tenure at Siebel, though that is rapidly changing these days. Matt currently serves as a Senior Advisor to SeventySix Capital, a leading early stage venture capital fund, and is on the Advisory Board at Crossix, an innovator in the healthcare analytics arena. Matt received his MBA from the Harvard Business School, with honors, and his BA in Economics from Yale University, cum laude.
Like what you see? Make sure you're getting it all
Authoritative coverage, data and analysis of deals across structured finance markets